CARISMA Therapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA, July 30, 2020 /PRNewswire/ --Carisma Therapeutics Inc. Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two virtual conferences in August 2020.

• LifeSci Partners Private Company Virtual Summer Symposium
  Tuesday, August 4, 2020 at 3:30 p.m. EDT
  
• Wedbush PacGrow Healthcare Virtual Conference
  Wednesday, August 12, 2020 at 12:35 p.m. EDT

About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.

For more information, please visit www.carismatx.com

Media Contact:
Christina Khoury-Folkens
612-806-0757
ckhoury@w2ogroup.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-upcoming-investor-conferences-301102672.html

SOURCE CARISMA Therapeutics Inc.